Grupo NC

Grupo NC is a large privately held Brazilian healthcare and diversified business group whose core pillar is pharmaceuticals. The group controls major pharma businesses including EMS, Germed, Legrand, Multilab Farma, Nova Química, Novamed, and interests in biologics through Bionovis, making it one of the largest pharmaceutical groups in Brazil. Its health businesses span R&D, manufacturing, commercialization, generics, branded medicines, OTC products, hospital products, ophthalmology, and selected innovative therapies. Grupo NC also maintains non-pharma activities in areas such as private equity, renewable energy, and real estate, but its identity is primarily anchored in healthcare and pharmaceutical manufacturing. For a biotech or pharma analyst, Grupo NC is best understood as the parent holding group behind EMS and a broad portfolio of commercial-stage pharmaceutical assets with substantial manufacturing and domestic market reach in Brazil.